Andrew Guggenhime - Jul 8, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
President and CFO
Signature
Andrew Guggenhime, by /s/ Ron Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Jul 8, 2022
Transactions value $
-$57,815
Form type
4
Date filed
7/12/2022, 05:12 PM
Previous filing
Sep 6, 2022
Next filing
Jul 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $16.6K +3.1K +7.35% $5.35 45.3K Jul 8, 2022 Direct
transaction PCVX Common Stock Sale -$74.4K -3.1K -6.85% $24.00 42.2K Jul 8, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -3.1K -0.62% $0.00 500K Jul 8, 2022 Common Stock 3.1K $5.35 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter.